Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
LXRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Loading LXRX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.15%72.471.2%$698.33m
CELGCelgene Corporation
0.71%117.391.3%$685.14m
AMGNAmgen Inc.
-0.15%145.071.0%$640.82m
BIIBBiogen Inc.
0.25%290.961.2%$543.42m
REGNRegeneron Pharmaceuticals, Inc.
-0.24%368.953.6%$400.43m
ALXNAlexion Pharmaceuticals, Inc.
-0.61%124.171.9%$372.24m
ILMNIllumina, Inc.
-1.19%126.403.0%$184.89m
VRTXVertex Pharmaceuticals Incorporated
3.40%78.122.9%$171.61m
INCYIncyte Corporation
2.34%107.212.4%$169.49m
TSROTESARO, Inc.
0.22%139.8717.1%$164.06m
IONSIonis Pharmaceuticals, Inc.
3.15%47.4510.0%$156.72m
EXELExelixis, Inc.
2.36%18.256.4%$128.45m
BLUEBluebird Bio, Inc.
9.43%78.9523.3%$121.32m
BMRNBioMarin Pharmaceutical Inc.
0.66%82.994.5%$116.36m
AAgilent Technologies, Inc.
0.72%44.851.6%$114.69m

Company Profile

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. Lexicon Pharmaceuticals was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.